EVALUATION OF THE LONG-TERM HEPATITIS A AND B ANTIBODY PERSISTENCE IN HEALTHY ADULT SUBJECTS, PRIMED 16 TO 20 YEARS EARLIER WITH GSK BIOLOGICALS' COMBINED HEPATITIS A AND B VACCINE, TWINRIX® (SB208127) IN STUDY HAB-084 (208127/084):